{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:21:28Z","timestamp":1790216488002,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":639,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1136\/esmoopen-2019-000535","type":"journal-article","created":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T05:44:16Z","timestamp":1571031856000},"page":"e000535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Stereotactic body radiation therapy in combination with systemic therapy for metastatic renal cell carcinoma: a prospective multicentre study"],"prefix":"10.1016","volume":"4","clinical-trial-number":[{"clinical-trial-number":"nct02864615","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Natalia","family":"Dengina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timur","family":"Mitin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Gamayunov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sufia","family":"Safina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliya","family":"Kreinina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7357-0392","authenticated-orcid":false,"given":"Ilya","family":"Tsimafeyeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/esmoopen-2019-000535_bb0010","doi-asserted-by":"crossref","first-page":"e1069","DOI":"10.1016\/j.clgc.2017.07.017","article-title":"Five-Year survival of patients with metastatic renal cell carcinoma in the Russian Federation: results from the RENSUR5 registry","volume":"15","author":"Tsimafeyeu","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"10.1136\/esmoopen-2019-000535_bb0015","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1200\/JCO.2005.04.8280","article-title":"Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence","volume":"24","author":"Eggener","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1136\/esmoopen-2019-000535_bb0020","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.critrevonc.2017.07.004","article-title":"Stereotactic ablative radiation therapy in renal cell carcinoma: from oligometastatic to localized disease","volume":"117","author":"Alongi","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1136\/esmoopen-2019-000535_bb0025","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.clgc.2016.09.004","article-title":"Current role of radiotherapy for renal-cell carcinoma: review","volume":"15","author":"Dengina","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"10.1136\/esmoopen-2019-000535_bb0030","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature12222","article-title":"Comprehensive molecular characterization of clear cell renal cell carcinoma","volume":"499","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"Nature"},{"key":"10.1136\/esmoopen-2019-000535_bb0035","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.ijrobp.2011.03.044","article-title":"Early significant tumor volume reduction after radiosurgery in brain metastases from renal cell carcinoma results in long-term survival","volume":"82","author":"Kim","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/esmoopen-2019-000535_bb0040","doi-asserted-by":"crossref","first-page":"e589","DOI":"10.1016\/j.prro.2015.05.004","article-title":"Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: is RCC truly radioresistant?","volume":"5","author":"Amini","year":"2015","journal-title":"Pract Radiat Oncol"},{"key":"10.1136\/esmoopen-2019-000535_bb0045","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/COC.0b013e31825d52b2","article-title":"Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma","volume":"36","author":"Ranck","year":"2013","journal-title":"Am J Clin Oncol"},{"key":"10.1136\/esmoopen-2019-000535_bb0050","doi-asserted-by":"crossref","first-page":"e1042198","DOI":"10.1080\/2162402X.2015.1042198","article-title":"The potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapy","volume":"4","author":"De Wolf","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1136\/esmoopen-2019-000535_bb0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2016.11.005","article-title":"Stereotactic ablative body radiosurgery (SABR) or stereotactic body radiation therapy (SBRT)","volume":"109","author":"Folkert","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1136\/esmoopen-2019-000535_bb0060","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1056\/NEJMoa1510665","article-title":"Nivolumab versus everolimus in advanced renal-cell carcinoma","volume":"373","author":"Motzer","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1136\/esmoopen-2019-000535_bb0065","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0167-8140(84)80074-2","article-title":"The radioresponsiveness of human tumours and the initial slope of the cell survival curve","volume":"2","author":"Deacon","year":"1984","journal-title":"Radiother Oncol"},{"key":"10.1136\/esmoopen-2019-000535_bb0070","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1002\/(SICI)1097-0142(19971215)80:12+<2519::AID-CNCR26>3.0.CO;2-E","article-title":"Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts","volume":"80","author":"Ning","year":"1997","journal-title":"Cancer"},{"key":"10.1136\/esmoopen-2019-000535_bb0075","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1126\/science.1082504","article-title":"Tumor response to radiotherapy regulated by endothelial cell apoptosis","volume":"300","author":"Garcia-Barros","year":"2003","journal-title":"Science"},{"issue":"10 Suppl","key":"10.1136\/esmoopen-2019-000535_bb0080","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1002\/cncr.24238","article-title":"Complexity of tumor vasculature in clear cell renal cell carcinoma","volume":"115","author":"Qian","year":"2009","journal-title":"Cancer"},{"key":"10.1136\/esmoopen-2019-000535_bb0085","doi-asserted-by":"crossref","first-page":"e170","DOI":"10.1016\/S1470-2045(13)70569-2","article-title":"Radiotherapy for renal-cell carcinoma","volume":"15","author":"De Meerleer","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1136\/esmoopen-2019-000535_bb0090","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3857\/roj.2016.01718","article-title":"Treatment outcome of radiation therapy and concurrent targeted molecular therapy in spinal metastasis from renal cell carcinoma","volume":"34","author":"Park","year":"2016","journal-title":"Radiat Oncol J"},{"key":"10.1136\/esmoopen-2019-000535_bb0095","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.clgc.2012.01.004","article-title":"Spontaneous regression of thoracic metastases while progression of brain metastases after stereotactic radiosurgery and stereotactic body radiotherapy for metastatic renal cell carcinoma: abscopal effect prevented by the blood-brain barrier?","volume":"10","author":"Ishiyama","year":"2012","journal-title":"Clin Genitourin Cancer"},{"key":"10.1136\/esmoopen-2019-000535_bb0100","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/02841860600604611","article-title":"Regression of non-irradiated metastases after extracranial stereotactic radiotherapy in metastatic renal cell carcinoma","volume":"45","author":"Wers\u00e4ll","year":"2006","journal-title":"Acta Oncol"},{"key":"10.1136\/esmoopen-2019-000535_bb0105","doi-asserted-by":"crossref","first-page":"15618","DOI":"10.1038\/ncomms15618","article-title":"Dna exonuclease TREX1 regulates radiotherapy-induced tumour immunogenicity","volume":"8","author":"Vanpouille-Box","year":"2017","journal-title":"Nat Commun"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702920301198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702920301198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/esmoopen-2019-000535","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:22:18Z","timestamp":1761855738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702920301198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"alternative-id":["S2059702920301198"],"URL":"https:\/\/doi.org\/10.1136\/esmoopen-2019-000535","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stereotactic body radiation therapy in combination with systemic therapy for metastatic renal cell carcinoma: a prospective multicentre study","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/esmoopen-2019-000535","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 THE AUTHORS. Published by Elsevier Limited on behalf of European Society for Medical Oncology; Originally published by BMJ.","name":"copyright","label":"Copyright"}],"article-number":"e000535"}}